Background: Kidney transplantation confers substantial survival and quality of life benefits for many patients with end-stage kidney disease compared with dialysis but complications and side-effects of immunosuppression can impair participation in daily life activities. Life participation is a critically important patient-reported outcome for kidney transplant recipients but it is inconsistently and infrequently measured in trials. We convened a consensus workshop on establishing a core outcome measure for life participation for use in all trials in kidney transplantation. Methods: Twenty-five (43%) kidney transplant recipients/caregivers and 33 (57%) health professionals from eight countries participated in six facilitated breakout group...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
Graft function and patient survival are traditionally the most used parameters to assess the objecti...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
BACKGROUND: Kidney transplantation confers substantial survival and quality of life benefits for man...
International audienceBACKGROUND: Kidney transplantation confers substantial survival and quality of...
For many patients with end‐stage kidney disease, transplantation improves survival and quality of li...
The escalating burden of end-stage kidney disease has spurred an increase in randomised trials in th...
Patient-reported outcomes (PROs) that assess individuals’ perceptions of life participation, medicat...
Background:Life participation is an outcome of critical importance to patients receiving peritoneal ...
Background:Life participation is an outcome of critical importance to patients receiving peritoneal ...
Research on medical treatment of chronic diseases focused initially on outcome parameters such as su...
BACKGROUND: Although advances in treatment have dramatically improved short-term graft survival and ...
Objective: to examine quality of life (QoL) and other patient-reported outcome measures (PROMs) in k...
International audienceThere are an estimated 14,000 randomized trials published in chronic kidney di...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
Graft function and patient survival are traditionally the most used parameters to assess the objecti...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
BACKGROUND: Kidney transplantation confers substantial survival and quality of life benefits for man...
International audienceBACKGROUND: Kidney transplantation confers substantial survival and quality of...
For many patients with end‐stage kidney disease, transplantation improves survival and quality of li...
The escalating burden of end-stage kidney disease has spurred an increase in randomised trials in th...
Patient-reported outcomes (PROs) that assess individuals’ perceptions of life participation, medicat...
Background:Life participation is an outcome of critical importance to patients receiving peritoneal ...
Background:Life participation is an outcome of critical importance to patients receiving peritoneal ...
Research on medical treatment of chronic diseases focused initially on outcome parameters such as su...
BACKGROUND: Although advances in treatment have dramatically improved short-term graft survival and ...
Objective: to examine quality of life (QoL) and other patient-reported outcome measures (PROMs) in k...
International audienceThere are an estimated 14,000 randomized trials published in chronic kidney di...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...
Graft function and patient survival are traditionally the most used parameters to assess the objecti...
There are an estimated 14,000 randomized trials published in chronic kidney disease. The most freque...